Macular Degeneration

Manufacturer: Newton Laboratories, Inc.
Effective date: 2011-06-01
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:05:14

Label at a glance#

ProductMacular Degeneration

Active ingredientMicrurus Corallinus Venom, Aconitum Napellus, Gold, Barium Carbonate, Atropa Belladonna, Crotalus Horridus Horridus Venom, Gelsemium Sempervirens Root, Hamamelis Virginiana Root Bark/stem Bark, Lachesis Muta Venom, Mercury, Phosphorus, Picric Acid, Lead, Pulsatilla Vulgaris, Toxicodendron Pubescens Leaf, Datura Stramonium, Theridion Curassavicum, Euphrasia Stricta

Label structure10 sections

Contacts and useful links#

PhoneLabel contact1.800.448.7256

Websitewww.newtonlabs.net

www.newtonlabs.net

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Macular Degeneration Formulated for symptoms of atrophic and neovascular forms of macular degeneration as well as symptoms associated with the macula and retina.

DOSAGE & ADMINISTRATION SECTION

Directions: Ages 12 and up, take 6 pellets orally one to four times daily or as directed by a healthcare professional.

ACTIVE INGREDIENT SECTION

OTC - ACTIVE INGREDIENT SECTION

Elaps corallinus 30x, Aconitum nap. 15x, Aur. met. 15x, Baryta carb. 15x, Belladonna 15x, Crotalus horridus 15x, Gelsemium 15x, Hamamelis 15x, Lachesis 15x, Merc. viv. 15x, Phosphorus 15x, Picricum ac. 15x, Plumbum met. 15x, Pulsatilla 15x, Rhus toxicodendron 15x, Stramonium 15x, Theridion 15x, Euphrasia 3x.

PURPOSE SECTION

ABUSE SECTION

Formulated for symptoms of atrophic and neovascular forms of macular degeneration as well as symptoms associated with the macula and retina.

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.

QUESTIONS? SECTION

OTC - QUESTIONS SECTION

www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256

WARNINGS SECTION

Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.

PREGNANCY OR BREAST FEEDING SECTION

OTC - PREGNANCY OR BREAST FEEDING SECTION

Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.

KEEP OUT OF REACH OF CHILDREN SECTION

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
55714-4599-1	2020-01-31	C162847	48780-1	9d75b9d0-2b54-f424-e053-dadaa90a57ce	Macular Degeneration
55714-4599-2	2020-01-31	C162847	48780-1	9d75b9d0-2b54-f424-e053-dadaa90a57ce	Macular Degeneration

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
55714-4599-1	Macular Degeneration	28.35 g in 1 BOTTLE, GLASS	PELLET	28.35		1
55714-4599-2	Macular Degeneration	56.7 g in 1 BOTTLE, GLASS	PELLET	56.7		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55714-4599	MACULAR DEGENERATION (ELAPS CORALLINUS, ACONITUM NAP.,AUR. MET., BARYTA CARB., BELLADONNA, CROTALUS HORRIDUS, GELSEMIUM, HAMAMELIS, LACHESIS, MERC. VIV.,PHOSPHORUS, PICRICUM AC., PLUMBUM MET., PULSATILLA,RHUS TOXICODENDRON, STRAMONIUM, THERIDION, EUPHRASIA) PELLET [NEWTON LABORATORIES, INC.]	1	Legacy NDC, 2 package rows	20131121_b0a80000-0d2d-23a8-2220-7576385e8894.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Aconitum Napellus	ACTIVE INGREDIENT	U0NQ8555JD	1
Atropa Belladonna	ACTIVE INGREDIENT	WQZ3G9PF0H	1
Barium Carbonate	ACTIVE INGREDIENT	6P669D8HQ8	1
Crotalus Horridus Horridus Venom	ACTIVE INGREDIENT	YHA2XLJ956	1
Datura Stramonium	ACTIVE INGREDIENT	G6W4F0V8Z3	1
Euphrasia Stricta	ACTIVE INGREDIENT	C9642I91WL	1
Gelsemium Sempervirens Root	ACTIVE INGREDIENT	639KR60Q1Q	1
Gold	ACTIVE INGREDIENT	79Y1949PYO	1
Hamamelis Virginiana Root Bark/stem Bark	ACTIVE INGREDIENT	T7S323PKJS	1
Lachesis Muta Venom	ACTIVE INGREDIENT	VSW71SS07I	1
Lead	ACTIVE INGREDIENT	2P299V784P	1
Mercury	ACTIVE INGREDIENT	FXS1BY2PGL	1
Micrurus Corallinus Venom	ACTIVE INGREDIENT	V0S6H36980	1
Phosphorus	ACTIVE INGREDIENT	27YLU75U4W	1
Picric Acid	ACTIVE INGREDIENT	A49OS0F91S	1
Pulsatilla Vulgaris	ACTIVE INGREDIENT	I76KB35JEV	1
Theridion Curassavicum	ACTIVE INGREDIENT	9Z8D3HEM8L	1
Toxicodendron Pubescens Leaf	ACTIVE INGREDIENT	6IO182RP7A	1
Aconitum Napellus	ACTIVE MOIETY	U0NQ8555JD	1
Atropa Belladonna	ACTIVE MOIETY	WQZ3G9PF0H	1
Barium Cation	ACTIVE MOIETY	V645272HLN	1
Crotalus Horridus Horridus Venom	ACTIVE MOIETY	YHA2XLJ956	1
Datura Stramonium	ACTIVE MOIETY	G6W4F0V8Z3	1
Euphrasia Stricta	ACTIVE MOIETY	C9642I91WL	1
Gelsemium Sempervirens Root	ACTIVE MOIETY	639KR60Q1Q	1
Gold	ACTIVE MOIETY	79Y1949PYO	1
Hamamelis Virginiana Root Bark/stem Bark	ACTIVE MOIETY	T7S323PKJS	1
Lachesis Muta Venom	ACTIVE MOIETY	VSW71SS07I	1
Lead	ACTIVE MOIETY	2P299V784P	1
Mercury	ACTIVE MOIETY	FXS1BY2PGL	1
Micrurus Corallinus Venom	ACTIVE MOIETY	V0S6H36980	1
Phosphorus	ACTIVE MOIETY	27YLU75U4W	1
Picric Acid	ACTIVE MOIETY	A49OS0F91S	1
Pulsatilla Vulgaris	ACTIVE MOIETY	I76KB35JEV	1
Theridion Curassavicum	ACTIVE MOIETY	9Z8D3HEM8L	1
Toxicodendron Pubescens Leaf	ACTIVE MOIETY	6IO182RP7A	1
Sucrose	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 22 matching rows.

Macular Degeneration
Elaps corallinus, Aconitum nap.,Aur. met., Baryta carb., Belladonna, Crotalus horridus, Gelsemium, Hamamelis, Lachesis, Merc. viv.,Phosphorus, Picricum ac., Plumbum met., Pulsatilla,Rhus toxicodendron, Stramonium, Theridion, Euphrasia
Micrurus Corallinus Venom
Aconitum Napellus
Gold
Barium Carbonate
Barium Cation
Atropa Belladonna
Crotalus Horridus Horridus Venom
Gelsemium Sempervirens Root
Hamamelis Virginiana Root Bark/stem Bark
Lachesis Muta Venom
Mercury
Phosphorus
Picric Acid
Lead
Pulsatilla Vulgaris
Toxicodendron Pubescens Leaf
Datura Stramonium
Theridion Curassavicum
Euphrasia Stricta
Sucrose

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
55714-4599	55714-4599-1, 55714-4599-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Micrurus Corallinus Venom	V0S6H36980	ACTIB
Aconitum Napellus	U0NQ8555JD	ACTIB
Gold	79Y1949PYO	ACTIB
Barium Carbonate	6P669D8HQ8	ACTIB
Atropa Belladonna	WQZ3G9PF0H	ACTIB
Crotalus Horridus Horridus Venom	YHA2XLJ956	ACTIB
Gelsemium Sempervirens Root	639KR60Q1Q	ACTIB
Hamamelis Virginiana Root Bark/stem Bark	T7S323PKJS	ACTIB
Lachesis Muta Venom	VSW71SS07I	ACTIB
Mercury	FXS1BY2PGL	ACTIB
Phosphorus	27YLU75U4W	ACTIB
Picric Acid	A49OS0F91S	ACTIB
Lead	2P299V784P	ACTIB
Pulsatilla Vulgaris	I76KB35JEV	ACTIB
Toxicodendron Pubescens Leaf	6IO182RP7A	ACTIB
Datura Stramonium	G6W4F0V8Z3	ACTIB
Theridion Curassavicum	9Z8D3HEM8L	ACTIB
Euphrasia Stricta	C9642I91WL	ACTIB
Sucrose	C151H8M554	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Sucrose	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, EMULSION / INTRAVENOUS		970 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		2000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTION / SUBCUTANEOUS	47.75 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / BUCCAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
Sucrose	SUCROSE	C151H8M554	INJECTABLE, LIPOSOMAL / INTRAVENOUS		7560 mg	Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
3a2e93e4-3405-038f-b134-22a5fd35dbf4			b0a80000-0d2d-23a8-2220-7576385e8894	2011-06-01	Warnings	Exact identifier spl id: 3a2e93e4-3405-038f-b134-22a5fd35dbf4 spl set id: b0a80000-0d2d-23a8-2220-7576385e8894

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.